Lizenzen und Reprints

Abstract

High-quality treatment of patients suffering from allergies should be a first priority of ENT specialists. In daily routine of otolaryngologists, allergic diseases play a significant role and have to be diagnosed and treated competently. A multitude of guidelines provide a clear corridor for identification of suitable methods. The most important sensitization tests such as skin tests and the determination of specific IgE in the serum lay the foundations of allergy diagnostics. Nasal provocation tests with allergens as most important and most frequently applied allergen provocation tests can be performed especially by highly qualified ENT specialists. They allow the determination of the clinical relevance of single allergens.

Beside pharmacotherapy and avoidance of allergens, the allergen-specific immunotherapy has a central position in the treatment of allergy diseases. Also in this context, correct indication and targeted selection of the pharmaceutics lead to an increased treatment quality.

In particular complex or severe allergic diseases require specialized and even highly specialized treatment. In Germany, structured requirements for establishing Comprehensive Allergy Centers have been developed. The involvement of otolaryngology in the further development of such centers should be improved.

Sound allergy education and training are the basis for competence and quality of the treatment of allergy patients. In medical studies, allergology is currently underrepresented. In specialization, some basic aspects of allergies are taken into account. The medical education for the additional specialization in allergology is currently changing; it is intended to be simplified but this might lead to devaluation. A full speciality of allergology does currently not exist in Germany.

In particular in the areas of allergy training, allergy research, and in the cooperation of ENT specialists in highly specialized allergy centers, an enormous potential for improvement is seen for the discipline of otolaryngology.

Abstract

High-quality treatment of patients suffering from allergies should be a first priority of ENT specialists. In daily routine of otolaryngologists, allergic diseases play a significant role and have to be diagnosed and treated competently. A multitude of guidelines provide a clear corridor for identification of suitable methods. The most important sensitization tests such as skin tests and the determination of specific IgE in the serum lay the foundations of allergy diagnostics. Nasal provocation tests with allergens as most important and most frequently applied allergen provocation tests can be performed especially by highly qualified ENT specialists. They allow the determination of the clinical relevance of single allergens.

Beside pharmacotherapy and avoidance of allergens, the allergen-specific immunotherapy has a central position in the treatment of allergy diseases. Also in this context, correct indication and targeted selection of the pharmaceutics lead to an increased treatment quality.

In particular complex or severe allergic diseases require specialized and even highly specialized treatment. In Germany, structured requirements for establishing Comprehensive Allergy Centers have been developed. The involvement of otolaryngology in the further development of such centers should be improved.

Sound allergy education and training are the basis for competence and quality of the treatment of allergy patients. In medical studies, allergology is currently underrepresented. In specialization, some basic aspects of allergies are taken into account. The medical education for the additional specialization in allergology is currently changing; it is intended to be simplified but this might lead to devaluation. A full speciality of allergology does currently not exist in Germany.

In particular in the areas of allergy training, allergy research, and in the cooperation of ENT specialists in highly specialized allergy centers, an enormous potential for improvement is seen for the discipline of otolaryngology.

• Literatur

• 1 Bergmann KC, Heinrich J, Niemann H. Current status of allergy prevalence in Germany: Position paper of the Environmental Medicine Commission of the Robert Koch Institute. Allergo J Int 2016; 25: 6-10
  CrossrefPubMedGoogle Scholar
• 2 Cingi C, Gevaert P, Mösges R. et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy 2017; 7: 17
  CrossrefPubMedGoogle Scholar
• 3 Bousquet J, Anto JM, Wickman M. et al. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy 2015; 70: 1062-1078
  CrossrefPubMedGoogle Scholar
• 4 Deming WE. Out of the crisis. Cambridge, Massachusetts: The MIT Press; 2018. xv 430 pages
  Google Scholar
• 5 Leitlinien ADWMFAWMF–SK „AWMF-Regelwerk „Leitlinien““ .2012. 3.10.2019. http://www.awmf.org/leitlinien/awmf-regelwerk.html
  PubMed
• 6 Klimek L, Bergmann KC, Biedermann T. et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int 2017; 26: 16-24
  PubMedGoogle Scholar
• 7 Ruëff F, Bergmann KC, Brockow K. et al. Hauttests zur Diagnostik von allergischen Soforttypreaktionen. Allergo J. 2010; 19: 402-415
  CrossrefPubMedGoogle Scholar
• 8 Bousquet J, Heinzerling L, Bachert C. et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012; 67: 18-24
  CrossrefPubMedGoogle Scholar
• 9 McCann WA, Ownby DR. The reproducibility of the allergy skin test scoring and interpretation by board-certified/board-eligible allergists. Ann Allergy Asthma Immunol 2002; 89: 368-371
  CrossrefPubMedGoogle Scholar
• 10 Mahler V. Testallergene: Aktueller Stand der Verfügbarkeit aus regulatorischer Sicht. Allergologie 2019; 42: 309-313
  PubMedGoogle Scholar
• 11 Mahler V, Becker D, Brasch J et al. AWMF-S3-Leitlinie. Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln. 2019;AWMF-Register-Nr.: 013-018 2019;
  PubMed
• 12 Bundesrat Allgemeine Verwaltungsvorschrift zur Änderung der Allgemeinen Verwaltungsvorschrift zum Verfahren der behördlichen Überwachung der Einhaltung der Grundsätze der Guten Laborpraxis. 2011
  PubMed
• 13 Renz H, Biedermann T, Bufe A. et al. In-vitro-Allergiediagnostik. Allergo J 2010; 19: 110-128
  CrossrefPubMedGoogle Scholar
• 14 Kleine-Tebbe J, Reese I, Ballmer-Weber B. et al. Keine Empfehlung für IgG-und IgG4-Bestimmungen gegen Nahrungsmittel. Allergo J 2009; 18: 267-273
  CrossrefPubMedGoogle Scholar
• 15 Haftenberger M, Laußmann D, Ellert U. et al. Prevalence of sensitisation to aeraoallergens and food allergens: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56: 687-697
  CrossrefPubMedGoogle Scholar
• 16 Burbach GJ, Heinzerling LM, Edenharter G. et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy 2009; 64: 1507-1515
  CrossrefPubMedGoogle Scholar
• 17 Worm M, Reese I, Ballmer-Weber B. et al. Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int 2015; 24: 256-293
  CrossrefPubMedGoogle Scholar
• 18 Brockow K, Przybilla B, Aberer W. et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo Journal International 2015; 24: 94-105
  PubMedGoogle Scholar
• 19 Przybilla B, Ruëff F, Walker A. et al. Diagnose und Therapie der Bienen-und Wespengiftallergie. Allergo Journal 2011; 20: 318-339
  CrossrefPubMedGoogle Scholar
• 20 Werfel T, Heratizadeh A, Aberer W. et al. S2k guideline on diagnosis and treatment of atopic dermatitis – short version. Allergo J Int 2016; 25: 82-95
  PubMedGoogle Scholar
• 21 Augé J, Vent J, Agache I. et al. EAACI Position paper on the standardization of nasal allergen challenges. Allergy 2018; 73: 1597-1608
  CrossrefPubMedGoogle Scholar
• 22 Kowalski ML, Agache I, Bavbek S. et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper. Allergy 2019; 74: 28-39
  CrossrefPubMedGoogle Scholar
• 23 Barry MJ, Edgman-Levitan S. Shared decision making – pinnacle of patient-centered care. N Engl J Med 2012; 366: 780-781
  CrossrefPubMedGoogle Scholar
• 24 Bousquet J, Hellings PW, Agache I. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019. 143 864-879
  Google Scholar
• 25 Loerbroks A, Tolksdorf SJ, Wagenmann M, Smith H. Food allergy knowledge, attitudes and their determinants among restaurant staff: A cross-sectional study. PLoS One 2019; 14: e0214625
  CrossrefPubMedGoogle Scholar
• 26 Promoting effective self-management programmes to improve COPD. [editorial]. Eur Respir J 2009; 33: 461
  CrossrefPubMedGoogle Scholar
• 27 Dinneen SF. Structured education for people with type 2 diabetes. BMJ 2008; 336: 459-460
  CrossrefPubMedGoogle Scholar
• 28 Chowdhury NI, Mace JC, Bodner TE. et al. Does Medical Therapy Improve SinoNasal Outcomes Test-22 Domain Scores? An Analysis of Clinically Important Differences. Laryngoscope 2019; 129: 31-36
  CrossrefPubMedGoogle Scholar
• 29 Biermann J, Merk HF, Wehrmann W, Klimek L, Wasem J. Allergic disorders of the respiratory tract – findings from a large patient sample in the German statutory health insurance system. Allergo Journal 2013; 22: 366-373
  CrossrefPubMedGoogle Scholar
• 30 Seyfert-Margolis V. The evidence gap. Nat Biotechnol 2018; 36: 228-232
  CrossrefPubMedGoogle Scholar
• 31 Valovirta E, Petersen TH, Piotrowska T. et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol 2018; 141: 529-538.e13
  CrossrefPubMedGoogle Scholar
• 32 Wahn U, Bachert C, Heinrich J, Richter H, Zielen S. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy 2019; 74: 594-604
  CrossrefPubMedGoogle Scholar
• 33 Kristiansen M, Dhami S, Netuveli G. et al. Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis. Pediatr Allergy Immunol 2017; 28: 18-29
  CrossrefPubMedGoogle Scholar
• 34 Purello-D’Ambrosio F, Gangemi S, Merendino RA. et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31: 1295-1302
  CrossrefPubMedGoogle Scholar
• 35 Pfaar O, Bachert C, Bufe A. et al. Leitlinie zur (allergen-) spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen. Allergo J Int 2014; 23: 282-319
  CrossrefPubMedGoogle Scholar
• 36 Brehler R, Klimek L, Vogelberg C, Werfel T, Pfaar O, Hamelmann E. Evidenz vs . Wirksamkeit am Beispiel von in Deutschland verkehrsfähigen Präparaten zur (allergen-) spezifischen Immuntherapie. Allergo J Int 2016; 38-43
  PubMedGoogle Scholar
• 37 Klimek L, Hamelmann E, Werfel T. Therapieallergene-Verordnung (TAV) und allergenspezifische Immuntherapie: Was darf man überhaupt noch verordnen?. Allergologie 2018; 41: 15-18
  CrossrefPubMedGoogle Scholar
• 38 Bachert C, Horn A, Wagenmann M, Brehmer D, Wahn U, Leserbrief zum Beitrag L, Klimek E. Hamelmann und T Werfel: Therapieallergene-Verordnung (TAV) und allergenspezifische Immuntherapie: Was darf man überhauptnoch verordnen?. Allergologie 2018; 41: 231-233
  PubMedGoogle Scholar
• 39 Klimek L, Werfel T, Vogelberg C. et al. Versuchte Verordnungssteuerung durch Fehlinterpretation. Allergo J 2018; 27: 78-80
  PubMedGoogle Scholar
• 40 Bundesrat Therapieallergene Verordnung. 2008; 1
  PubMed
• 41 Wollenberg A, Barbarot S, Bieber T. et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. [letter]. J Eur Acad Dermatol Venereol 2018; 32: 850-878
  CrossrefPubMedGoogle Scholar
• 42 Schulz M, Martin E, Dalhoff K. et al. Nationale VersorgungsLeitlinie Asthma. www.asthmaversorgungsleitliniende 20181-106
  PubMedGoogle Scholar
• 43 Buhl R, Bals R, Baur X et al. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. AWMF-Registernummer 020-009 httpswwwawmforgleitliniendetailll-html 2017
  PubMed
• 44 Zuberbier T, Aberer W, Asero R. et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018; 73: 1393-1414
  CrossrefPubMedGoogle Scholar
• 45 Chaker AM. Biologics in Rhinology – Forthcoming Personalized Concepts: the Future Starts Today. Laryngorhinootologie 2018; 97: S142-S184
  Artikel in Thieme ConnectPubMedGoogle Scholar
• 46 Palomares O, Untersmayr E, Gutermuth J et al. Biologicals in allergic diseases and asthma: Towards personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy 2019
  PubMed
• 47 Han Y, Chen Y, Liu X. et al. Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials.[letter]. J Allergy Clin Immunol 2017; 140: 888-891.e6
  CrossrefPubMedGoogle Scholar
• 48 Bousquet J, Lund VJ, van Cauwenberge P. et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003; 58: 733-741
  CrossrefPubMedGoogle Scholar
• 49 Sleurs K, Seys S, Bousquet J et al. Mobile health tools for the management of chronic respiratory diseases. Allergy 2019
  PubMed
• 50 Pugin B, Deneyer L, Bachert C. et al. Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative. Rhinology 2019; 57: 331-335
  PubMedGoogle Scholar
• 51 “Netzwerk allergologischer Referenzzentren”. Berlin, 2014. 5.10.2019 2019. <https://dgaki.de/cac/>
  PubMed
• 52 “CAC-Zertifizierungsprozess.” Berlin, 2014. 5.10.2019 2019. <https://dgaki.de/cac/checklisten/>
  PubMed
• 53 Bundesärztekammer. (Muster-)Weiterbildungsordnung. Berlin: Bundesärztekammer; 2018: 1
  Google Scholar
• 54 Bundesärztekammer. Gebiet Hals-Nasen-Ohrenheilkunde. Facharzt/Fachärztin für Hals-Nasen-Ohrenheilkunde. In Ärztekammern ADD. editor (Muster-) Weiterbildungsordnung; 2018. p 92-97
  CrossrefGoogle Scholar
• 55 Arbeitsgemeinschaft Klinische Immunologie AUU, DGHNO-KHC. “Richtlinien des Grund- und Aufbaukurses „Allergologie. in der HNO-Heilkunde“.” Ed DGHNO-KHC. 1.10.2019 2019. <https://allergologie.hno.org/storage/app/media/PDF/RichtlinienAllergiekurse.pdf>
  PubMedGoogle Scholar
• 56 Bundesärztekammer. Zusatz-Weiterbildung Allergologie. In Ärztekammern ADD. editor (Muster-)Weiterbildungsordnung; 2018. p 299-301
  Google Scholar
• 57 Worm M, Francuzik W, Renaudin JM. et al. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy 2018; 73: 1322-1330
  CrossrefPubMedGoogle Scholar
• 58 editor 121. Deutscher Ärztetag. Beschlussprotokoll. 2018 Berlin: Bundesärztekammer (Arbeitsgemeinschaft der deutschen Ärztekammern); 2018
  PubMedGoogle Scholar
• 59 Werfel T. Allergologen-Ausbildung auf dem Holzweg. Allergo J 2018; 27: 64
  PubMedGoogle Scholar
• 60 Gerth van Wijk R. Stellungnahme der UEMS zur neuen Musterweiterbildungsordnung Allergologie (an die DGAKI). Allergo J 2018; 27: 65
  PubMedGoogle Scholar
• 61 Gerth van Wijk R, Eguiluz-Gracia I, Gayraud J. et al. The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement. Allergy 2018; 73: 540-548
  CrossrefPubMedGoogle Scholar
• 62 Malling HJ, Gayraud J, Papageorgiu-Saxoni P, Hornung B, Rosado-Pinto J, Del Giacco SG. Objectives of training and specialty training core curriculum in allergology and clinical immunology. Allergy 2004; 59: 579-588
  CrossrefPubMedGoogle Scholar
• 63 Fyhrquist N, Werfel T, Bilò MB, Mülleneisen N, Gerth van Wijk R. The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper. Clin Transl Allergy 2019; 9: 3
  CrossrefPubMedGoogle Scholar
• 64 Panesar SS, Javad S, de Silva D. et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68: 1353-1361
  CrossrefPubMedGoogle Scholar
• 65 Langen U, Schmitz R, Steppuhn H. Prevalence of allergic diseases in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56: 698-706
  CrossrefPubMedGoogle Scholar